Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Autoformación asistida por ordenador para mejorar la función ejecutiva (COMPEX)

29 de septiembre de 2026 actualizado por: Hanne Christensen, Bispebjerg Hospital

Computer-Assisted Self-Training to Improve Executive Function Versus Unspecific Training in Patients After Stroke, Cardiac Arrest or in Parkinson's Disease: A Randomized Controlled Trial

This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to generally cognitively stimulating activities on a computer

Descripción general del estudio

Descripción detallada

This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to completing generally cognitively stimulating activities on a computer. A total of 307 patients is expected to be enrolled. All patients will complete a neuropsychological test battery assessing executive functions at inclusion, directly after the eight-week training period and at follow-up three months after the end of the intervention period. Furthermore, all patients will answer questionnaires concerning quality of life and ADL-measures at baseline, after the intervention and at follow-up. All patients will train for a period of 8 weeks, 5 times a week for 60 minutes regardless of their group allocation.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

307

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Copenhagen, Dinamarca
        • Rigshospitalet
      • Copenhagen, Dinamarca
        • Bispebjerg Hospital

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 100 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • A diagnose of stroke, cardiac arrest or Parkinson's disease.
  • Aged 18 years or older.
  • Impaired working memory measured with CABPad working memory test, cut off for inclusion: 5 symbols or less backwards
  • Computer and internet access at home.
  • Providing informed consent.

Inclusion criteria specific for stroke

  • Inclusion within 6 months post-stroke
  • Stroke confirmed by clinical findings and imaging, both AIS and ICH is allowed.
  • Initial stroke severity >/= NIHSS 3.

Inclusion criteria specific for cardiac arrest

• Inclusion within 6 months post ictus.

Inclusion criteria specific for Parkinson's disease

  • Clinical diagnosis of PD.
  • Anti-parkinsonian medical treatment (dopaminergic or other).

Exclusion Criteria:

  • Informed consent not provided
  • Other neurological or psychiatric disease which is expected to influence the patient's ability to participate in the trial according to the investigator
  • Not able to participate according to investigator

Exclusion criteria specific for stroke

  • Patients with massive anosognosia for executive dysfunction or patients with no subjective feeling of executive dysfunction (Patient sustains total denial of executive symptoms over time)
  • Patients with severe aphasia, in which it is unclear whether the patient's performance on a neuropsychological test-battery is due to aphasia and not executive dysfunction.

Exclusion criteria specific for cardiac arrest • None

Exclusion criteria specific for PD

• Diagnosis of PD Dementia according to the MDS PD Dementia criteria

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Specific computer-based cognitive rehabilitation

154 patients will be allocated to specific computer-based cognitive rehabilitation. This group will train with 10 exercises from the cognitive rehabilitation software 'Scientific Brain training PRO'. These 10 exercises are designed to train various executive functions.

CBCR are software-programmes for computers which are clinically developed for rehabilitation of various cognitive functions.

Comparador activo: General computer-based cognitive stimulation

154 patients will be allocated to general computer-based cognitive stimulation. This group will train with 10 generally mentally stimulating games on a website specifically designed for this trial. These 10 games are chosen because they are believed to have a low load on executive functions but stimulate over-all concentration and visuoperceptual abilities.

For this trial we have developed a webpage for general cognitive stimulation, which is designed to provide general computer-based cognitive stimulation.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
CABPad Working Memory Test
Periodo de tiempo: After the end of the intervention (8 weeks after baseline)

Test of working memory. The higher score the better (theoretically infinite score)

After the end of the intervention (8 weeks after baseline)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
CABPad Working Memory Test - 3 months follow-up
Periodo de tiempo: At follow-up visit 3 months after end of intervention

Test of working memory. The higher score the better (theoretically infinite score)

At follow-up visit 3 months after end of intervention
Minimum Data Set-Home Care- Instrumental Activities of Daily Living (MDS-HC-IADL)
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention

Questionnaire concerning activities of daily living. 0-3 points on an 8-item scale, the fewer points the better.

At follow-up visit 3 months after the end of the intervention
Trail Making A
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion

Test of processing speed and visual attention. The lower score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
Trail Making A
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention

Test of processing speed and visual attention. The lower score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
Trail Making B
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion

Test of divided attention, mental flexibility. The lower score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
Trail Making B
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention

Test of divided attention, mental flexibility. The lower score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
SDMT
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion

Symbol Digit Modalities Test: Test of mental speed. The higher score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
SDMT
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention

Symbol Digit Modalities Test: Test of mental speed. The higher score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
Phonological verbal fluency test
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion

Test of verbal phonological fluency. The higher score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
Phonological verbal fluency test
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention

Test of verbal phonological fluency. The higher score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
Categorical verbal fluency test
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion

Test of verbal categorical fluency. The higher score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
Categorical verbal fluency test
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention

Test of verbal categorical fluency. The higher score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
Fear questionnaire
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion

Questionnaire with 24 items concerning fear on a scale from 0 to 8 where 8 indicates a higher degree of avoidance due to fear

Directly after the intervention, eight weeks after inclusion
Fear questionnaire
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention

Questionnaire with 24 items concerning fear on a scale from 0 to 8 where 8 indicates a higher degree of avoidance due to fear

At follow-up visit 3 months after the end of the intervention
mrs: Modified Rankin Scale
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion

Questionnaire concerning disability on a scale from 0 (no symptoms) to 6 (dead): Higher score indicates more severe disability.

Directly after the intervention, eight weeks after inclusion
mrs: Modified Rankin Scale
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention

Questionnaire concerning disability on a scale from 0 (no symptoms) to 6 (dead). Higher score indicates more severe disability.

At follow-up visit 3 months after the end of the intervention
IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly)
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion

Cognitive decline in the elderly, reported by partner. A scale of 16 items from 1 (much better) to 5 (much worse). Higher score indicates more severe disability.

Directly after the intervention, eight weeks after inclusion
IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly)
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention

Cognitive decline in the elderly, reported by partner. A scale of 16 items from 1 (much better) to 5 (much worse). Higher score indicates more severe disability.

At follow-up visit 3 months after the end of the intervention
EuroQol-5 domain (EQ-5D-5L)
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion

Quality of life scale with 5 domains, each rated from 1-5 indicating slight to severe disability . Higher score indicates more severe disability. Completed by patient and partner

Directly after the intervention, eight weeks after inclusion
EuroQol-5 domain (EQ-5D-5L)
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention

Quality of life scale with 5 domains, each rated from 1-5 indicating slight to severe disability. Higher score indicates more severe disability. Completed by patient and partner

At follow-up visit 3 months after the end of the intervention
PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinson Disease)
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion

Quality of Life questionnaire in patients with Parkinson's Disease. A scale with 39 items rated from 1 (never) to 5 (all the time / Can not do at all). Higher score indicates more severe disability.

Directly after the intervention, eight weeks after inclusion
PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinsons Disease)
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention

Quality of Life questionnaire in patients with Parkinson's Disease. A scale with 39 items rated from 1 (never) to 5 (all the time / Can not do at all). Higher score indicates more severe disability.

At follow-up visit 3 months after the end of the intervention
Compliance
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion

Monitoring of total time spent training in minutes

Directly after the intervention, eight weeks after inclusion
PHQ-9 (Patient health questionnaire 9)
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion

Questionnaire about health of patient with 9 items rated on a 4 point scale from 0 (not at all) to 3 (almost every day). Higher score indicates more severe disability.

Directly after the intervention, eight weeks after inclusion
PHQ-9 (Patient health questionnaire 9)
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention

Questionnaire about health of patient with 9 items rated on a 4 point scale from 0 (not at all) to 3 (almost every day). Higher score indicates more severe disability.

At follow-up visit 3 months after the end of the intervention
2) visual analogue scale (1-10)
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion

After last session: how much they liked doing the training and if they would recommend the intervention to somebody else in their situation. Higher score indicates they liked the training more.

Directly after the intervention, eight weeks after inclusion
Minimum Data Set-Home Care- Instrumental Activities of Daily Living (MDS-HC-IADL)
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion

Questionnaire concerning activities of daily living. 0-3 points on an 8-item scale, the fewer points the better.

Directly after the intervention, eight weeks after inclusion

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de junio de 2020

Finalización primaria (Estimado)

5 de noviembre de 2026

Finalización del estudio (Estimado)

5 de febrero de 2027

Fechas de registro del estudio

Enviado por primera vez

3 de enero de 2020

Primero enviado que cumplió con los criterios de control de calidad

13 de enero de 2020

Publicado por primera vez (Actual)

14 de enero de 2020

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

2 de octubre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

29 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Descripción del plan IPD

This is currently undecided

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir